These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355 [TBL] [Abstract][Full Text] [Related]
4. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression. Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859 [TBL] [Abstract][Full Text] [Related]
6. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type. Aishima S; Fujita N; Mano Y; Kubo Y; Tanaka Y; Taketomi A; Shirabe K; Maehara Y; Oda Y Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073 [TBL] [Abstract][Full Text] [Related]
7. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour. Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244 [TBL] [Abstract][Full Text] [Related]
8. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma. Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431 [TBL] [Abstract][Full Text] [Related]
9. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Su MC; Hsu C; Kao HL; Jeng YM Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303 [TBL] [Abstract][Full Text] [Related]
10. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma. Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797 [TBL] [Abstract][Full Text] [Related]
11. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841 [TBL] [Abstract][Full Text] [Related]
12. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823 [TBL] [Abstract][Full Text] [Related]
13. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'. Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067 [TBL] [Abstract][Full Text] [Related]
14. Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. Thelen A; Scholz A; Benckert C; Weichert W; Dietz E; Wiedenmann B; Neuhaus P; Jonas S Ann Surg Oncol; 2008 Mar; 15(3):791-9. PubMed ID: 18172731 [TBL] [Abstract][Full Text] [Related]
15. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma. Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576 [TBL] [Abstract][Full Text] [Related]
17. Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Okabe H; Beppu T; Hayashi H; Horino K; Masuda T; Komori H; Ishikawa S; Watanabe M; Takamori H; Iyama K; Baba H Ann Surg Oncol; 2009 Sep; 16(9):2555-64. PubMed ID: 19548033 [TBL] [Abstract][Full Text] [Related]
18. Relationship between microvessel count and postoperative survival in patients with intrahepatic cholangiocarcinoma. Nanashima A; Shibata K; Nakayama T; Tobinaga S; Araki M; Kunizaki M; Takeshita H; Hidaka S; Sawai T; Nagayasu T; Tagawa T Ann Surg Oncol; 2009 Aug; 16(8):2123-9. PubMed ID: 19434454 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma. Terashi T; Aishima S; Taguchi K; Asayama Y; Sugimachi K; Matsuura S; Shimada M; Maehara S; Maehara Y; Tsuneyoshi M Liver Int; 2004 Feb; 24(1):38-45. PubMed ID: 15101999 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma. Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]